Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients (NQF 0385)

EMeasure Name Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients EMeasure Id BA97BDE5-5347-4083-BED1-81EB156D9B81
Version number 1 Set Id D5E14C3C-BED4-4B9F-A8B2-EFF55AA52E39
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward American Medical Association - Physician Consortium for Performance Improvement
Endorsed by National Quality Forum
Description Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period
Copyright
© 2010 American Medical Association. All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
Patients with Stage IIIA through Stage IIIC colon cancer do not always receive the recommended treatment of adjuvant chemotherapy. This measure is intended to determine whether and how often chemotherapy is administered. The specific chemotherapy drugs specified in this measure reflect the most current guidelines of the National Comprehensive Cancer Network.
Clinical Recommendation Statement
Following primary surgical treatment, the panel recommends six months of 5-fluorouracil/leucovorin capecitabine, or 5-fluorouracil / leucovorin / oxaliplatin as adjuvant chemotherapy for patients with stage III (T1-4, N1-2, M0) colon cancer (Category 2A) (NCCN).
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
National Comprehensive Cancer Network (NCCN).  Clinical Practice Guidelines in Oncology:  Colon Cancer.  Version 1, 2007.  Available at:  http://www.nccn.org/professionals/physician_gls/PDF/colon.pdf.
Definition
Guidance
The numerator statement for this measure includes patients who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or who have previously received adjuvant chemotherapy. "Referred for Chemotherapy" is not separately specified, as this option can be captured either through the "Medication ordered: Chemotherapy for Colon Cancer" numerator option or the patient reason exclusion: "Medication administered not done: Patient reason" for "Chemotherapy for Colon Cancer RxNorm."

Table of Contents


Population criteria

Data criteria (QDS Data Elements)

Summary Calculation

Calculation is generic to all measures:



Measure set CLINICAL QUALITY MEASURE SET 2011-2012